![mechanism of action of glp 1 receptor agonist glp-1 [25] Glucagon-Like Peptide Agonists Glucagon Receptor Agonist Merck pays $112M upfront Type:Paperback](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3892010842765505871)
![mechanism of action of glp 1 receptor agonist glp-1 [25] Glucagon-Like Peptide Agonists Glucagon Receptor Agonist Merck pays $112M upfront Type:Paperback](https://www.mdpi.com/biomedicines/biomedicines-13-01924/article_deploy/html/images/biomedicines-13-01924-g001.png)
![mechanism of action of glp 1 receptor agonist glp-1 [25] Glucagon-Like Peptide Agonists Glucagon Receptor Agonist Merck pays $112M upfront Type:Paperback](https://diabetesed.net/wp-content/uploads/2025/09/gLP-cheat-sheet.webp)
![mechanism of action of glp 1 receptor agonist glp-1 [25] Glucagon-Like Peptide Agonists Glucagon Receptor Agonist Merck pays $112M upfront Type:Paperback](https://www.contemporaryhealth.co.uk/wp-content/uploads/2025/09/closeup-ozempic-pen-diabetes-management.jpg)
Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Oct 25 - Oct 30
mechanism of action of glp 1 receptor agonist glp-1 [25] Glucagon-Like Peptide Agonists Glucagon Receptor Agonist Merck pays $112M upfront Type:Paperback
Merck pays $112M upfront for Hansoh's preclinical GLP-1
Ideal candidates typically: Have struggled with weight control despite lifestyle modification Display signs of insulin resistance or metabolic syndrome Require medical assistance to prevent progression of obesity-related diseases Exclusion criteria may include individuals with a history of certain endocrine disorders, pancreatitis, or specific gastrointestinal diseases
Glucagon Receptor Agonist
Type:Paperback
34 (4), e2982
US$ 22.67
US$ 22.70
US$ 21.37
US$ 20.80
US$ 21.23
US$ 22.83
US$ 23.80
